Minnesota Chemoprevention Consortium



You are invited to the next meeting of the
Minnesota Chemoprevention Consortium

Wednesday, October 27, 2021
12:00 – 3:00 p.m.

* Lunch will be provided *

Hormel Foods Corporation R&D
2107 8th Dr NE • Austin, MN 55912

This will be a hybrid in person/Zoom event
Register now at: z.umn.edu/MC2signup

Presentations at this meeting will include:

Translational immunotherapy of malignant melanoma
Svetomir Markovic, MD, PhD
Professor of Medicine, Division of Medical Oncology, Department of Oncology
Mayo Clinic

Dose-finding trial designs when the optimal dose may differ by patient
Anne Eaton, PhD
Assistant Professor, Division of Biostatistics
Masonic Cancer Center, University of Minnesota

The role of histone H3 mutations in pediatric brain tumors
James Robinson, PhD
Assistant Professor, Cell Signaling & Tumorigenesis
The Hormel Institute, University of Minnesota

Meeting will conclude with a tour of the Hormel R&D labs

Have a proposal or data you'd like to present at a future meeting?
Contact Dr. Ilana Chefetz Menaker at ichefetz@umn.edu

About MC2: The Minnesota Chemoprevention Consortium (MC2) is a venture formed collaboratively by investigators at the Masonic Cancer Center - University of Minnesota, Mayo Clinic, Hormel Institute, Southern Research and Outreach Center, and Hormel Foods. The mission statement of MC2: To facilitate and implement interdisciplinary agent development and delivery for cancer prevention.